西罗莫司转换在肾移植受者中的应用

被引:13
作者
文吉秋
季曙明
尹广
机构
[1] 南京军区南京总医院解放军肾脏病研究所
关键词
肾脏移植; 免疫抑制剂; 西罗莫司; 转换治疗;
D O I
暂无
中图分类号
R699 [泌尿及男性生殖系外科学];
学科分类号
100210 [外科学];
摘要
引用
收藏
页码:483 / 487
页数:5
相关论文
共 22 条
[1]
Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction [J].
Krueger, B. ;
Fischereder, M. ;
Jauch, K-W. ;
Graeb, C. ;
Hoffmann, U. ;
Boeger, C. A. ;
Banas, B. ;
Obed, A. ;
Schlitt, H. J. ;
Kraemer, B. K. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (02) :518-521
[2]
Kidney Transplantation With Sirolimus and Mycophenolate Mofetil–Based Immunosuppression: 5-Year Results of a Randomized Prospective Trial Compared to Calcineurin Inhibitor Drugs.[J].Stuart M. Flechner;David Goldfarb;Kim Solez;Charles S. Modlin;Barbara Mastroianni;Kathy Savas;Denise Babineau;Sunil Kurian;Daniel Salomon;Andrew C. Novick;Daniel J. Cook.Transplantation.2007, 7
[3]
Chronic allograft nephropathy: current concepts and future directions [J].
Nankivell, BJ ;
Chapman, JR .
TRANSPLANTATION, 2006, 81 (05) :643-654
[4]
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies [J].
Kauffman, HM ;
Cherikh, WS ;
Cheng, YL ;
Hanto, DW ;
Kahan, BD .
TRANSPLANTATION, 2005, 80 (07) :883-889
[5]
Improvement of Renal Dysfunction by Conversion From Calcineurin Inhibitors to Sirolimus After Heart Transplantation.[J].Judson Hunt;Mark Lerman;Mitchell J. Magee;Todd M. Dewey;Morley Herbert;Michael J. Mack.Journal of Heart and Lung Transplantation.2005, 11
[6]
Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials [J].
Mulay, AV ;
Hussain, N ;
Fergusson, D ;
Knoll, GA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (07) :1748-1756
[7]
Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience [J].
Weber, T ;
Abendroth, D ;
Schelzig, H .
TRANSPLANT INTERNATIONAL, 2005, 18 (02) :151-156
[8]
Early cyclosporine A withdrawal in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions [J].
Ruiz, JC ;
Campistol, JM ;
Grinyó, JM ;
Mota, A ;
Prats, D ;
Gutiérrez, JA ;
Henriques, AC ;
Pinto, JR ;
García, J ;
Morales, JM ;
Gómez, JM ;
Arias, M .
TRANSPLANTATION, 2004, 78 (09) :1312-1318
[9]
Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology [J].
Nankivell, BJ ;
Borrows, RJ ;
Fung, CLS ;
O'Connell, PJ ;
Chapman, JR ;
Allen, RDM .
TRANSPLANTATION, 2004, 78 (04) :557-565
[10]
Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma [J].
Campistol, JM ;
Gutierrez-Dalmau, A ;
Torregrosa, JV .
TRANSPLANTATION, 2004, 77 (05) :760-762